The eyes are no longer just a window to the outside world — they are now emerging as a powerful window into the body’s internal health. Dr. Gopal S. Pillai, Head of the Department of Ophthalmology at Amrita Hospital, Kochi, has brought national attention to himself and the institution by developing an artificial intelligence (AI) technology that can predict the risk of heart attacks, strokes, and kidney diseases by analyzing the retina of the eye. In recognition of this groundbreaking achievement, he has been honoured with the prestigious Elsevier RAISE Award, which celebrates excellence in healthcare innovation.

The retina is the only part of the human body where blood vessels and nerves can be directly visualized without any surgical intervention. Leveraging this unique advantage, Dr. Gopal S. Pillai and his team developed an AI-powered system called “Reti AI.” By conducting a detailed analysis of retinal images, the technology can accurately estimate an individual’s risk of developing heart disease, kidney disorders, or stroke. Among numerous entries from across the country, this project secured first place in the “Ethical Clinical AI” category. The project team included Amrita Hospital doctors Dr. Rajesh T., Dr. Vivek Nambiar, Dr. Merin Dixon, Dr. Nagesh Subbanna, Dr. Aishwarya A., Rahul, and Anjana.

This technology has been entirely developed in India. It enables early identification of potential health threats even before symptoms appear, allowing timely medical intervention and preventing serious complications. More than just a technological innovation, the system’s strong commitment to ethical values is what made it deserving of this prestigious award.

This invention stands as an excellent example of how artificial intelligence can be safely and responsibly used in healthcare for the benefit of humanity.